Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis

Basic Research in Cardiology

Volumn 108, Issue 1, 2013, Pages

  Kanzler, Isabella ^a,b,e   Tuchscheerer, Nancy ^a,b   Steffens, Guy ^a   Simsekyilmaz, Sakine ^b   Konschalla, Simone ^b   Kroh, Andreas ^b   Simons, David ^a,f   Asare, Yaw ^a   Schober, Andreas ^b   Bucala, Richard ^d   Weber, Christian ^b,c   Bernhagen, Jürgen ^a   Liehn, Elisa A ^a,b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e GOETHE UNIVERSITY   (Germany)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Angiogenesis; Chemokine; CXC; Embryonic endothelial progenitor cell (eEPC); Hypoxia; Macrophage migration inhibitory factor (MIF)

Indexed keywords

CD74 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CXC CHEMOKINE RECEPTOR; CXCL1 CHEMOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR; MIF RECEPTOR; RECEPTOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CELL ADHESION; CELL DIFFERENTIATION; CELL HYPOXIA; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SMOOTH MUSCLE FIBER; UPREGULATION;

EID: 84869890292     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-012-0310-4     Document Type: Article

References (47)

1. Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE (2003) Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 93:321-329. doi: 10.1161/01.RES.0000087641.56024.DA (Pubitemid 37048244)
2. Anghelina M, Krishnan P, Moldovan L, Moldovan NI (2004) Monocytes and macrophages form branched cell columns in matrigel: implications for a role in neovascularization. Stem Cells Dev 13:665-676. doi: 10.1089/scd.2004.13.665 (Pubitemid 40052643)
3. Anghelina M, Krishnan P, Moldovan L, Moldovan NI (2006) Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. Am J Pathol 168:529-541 (Pubitemid 43271151)
4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967. doi: 10.1126/science.275.5302.964 (Pubitemid 27087709)
5. Belo AV, Leles F, Barcelos LS, Ferreira MA, Bakhle YS, Teixeira MM, Andrade SP (2005) Murine chemokine CXCL2/KC is a surrogate marker for angiogenic activity in the inflammatory granulation tissue. Microcirculation 12:597-606. doi: 10.1080/10739680500253535 (Pubitemid 41632177)
6. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, Kooistra T, Fingerle-Rowson G, Ghezzi P, Kleemann R, McColl SR, Bucala R, Hickey MJ, Weber C (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587-596. doi: 10.1038/nm1567 (Pubitemid 46828480)
7. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration Inhibitory factor (MIF). Biochemistry 33:14144-14155 (Pubitemid 24382359)
8. Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9:653-660. doi: 10.1038/nm0603-653 (Pubitemid 36749213)
9. Carmeliet P (2000) VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med 6:1102-1103. doi: 10.1038/80430
10. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864. doi: 10.1038/nm1075 (Pubitemid 39070860)
11. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R (1999) An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 5:181-191 (PMCID: PMC2230298) (Pubitemid 29252666)
12. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, Bruno S, Bussolati B, Camussi G (2007) Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110:2440-2448. doi: 10.1182/blood-2007-03- 078709 (Pubitemid 47523165)
13. Dewor M, Steffens G, Krohn R, Weber C, Baron J, Bernhagen J (2007) Macrophage migration inhibitory factor (MIF) promotes fibroblast migration in scratch-wounded monolayers in vitro. FEBS Lett 581:4734-4742. doi: 10.1016/j.febslet.2007.08.071 pii: S0014-5793(07)00958-1 (Pubitemid 47418800)
14. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4-25. doi: 10.1210/er.18.1.4 (Pubitemid 27076453)
15. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676. doi: 10.1038/nm0603-669 (Pubitemid 36749215)
16. Flieger O, Engling A, Bucala R, Lue H, Nickel W, Bernhagen J (2003) Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett 551:78-86 pii:S0014579303009001 (Pubitemid 37281331)
17. Folkman J (1998) Angiogenic therapy of the human heart. Circulation 97:628-629. doi: 10.1161/01.CIR.97.7.628 (Pubitemid 28090952)
18. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N (1999) VEGF is required for growth and survival in neonatal mice. Development 126:1149-1159 (Pubitemid 29182112)
19. Grieb G, Piatkowski A, Simons D, Hormann N, Dewor M, Steffens G, Bernhagen J, Pallua N (2012) Macrophage migration inhibitory factor is a potential inducer of endothelial progenitor cell mobilization after flap operation. Surgery 151:268-277.e261. doi: 10.1016/j.surg.2010.10.008
20. Hatzopoulos AK, Folkman J, Vasile E, Eiselen GK, Rosenberg RD (1998) Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 125:1457-1468 (Pubitemid 28239355)
21. Hinkel R, El-Aouni C, Olson T, Horstkotte J, Mayer S, Muller S, Willhauck M, Spitzweg C, Gildehaus FJ, Munzing W, Hannappel E, Bock-Marquette I, DiMaio JM, Hatzopoulos AK, Boekstegers P, Kupatt C (2008) Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Circulation 117:2232-2240. doi: 10.1161/CIRCULATIONAHA.107. 758904
22. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288-293. doi: 10.1161/01.ATV.0000114236.77009.06 (Pubitemid 38197580)
23. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752-2760. doi: 10.1182/blood-2004-04-1396 (Pubitemid 39434958)
24. Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM (2004) Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 172:2853-2860 (Pubitemid 38263670)
25. Klug MG, Soonpaa MH, Koh GY, Field LJ (1996) Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Investig 98:216-224. doi: 10.1172/JCI118769 (Pubitemid 26243839)
26. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S (2005) Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105:3793-3801. doi: 10.1182/blood-2004-11-4349 (Pubitemid 40656121)
27. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ (2005) Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23:879-894. doi: 10.1634/stemcells.2004-0342 (Pubitemid 41170944)
28. Kupatt C, Bock-Marquette I, Boekstegers P (2008) Embryonic endothelial progenitor cell-mediated cardioprotection requires Thymosin beta4. Trends Cardiovasc Med 18:205-210. doi: 10.1016/j.tcm.2008.10.002
29. Kupatt C, Horstkotte J, Vlastos GA, Pfosser A, Lebherz C, Semisch M, Thalgott M, Buttner K, Browarzyk C, Mages J, Hoffmann R, Deten A, Lamparter M, Muller F, Beck H, Buning H, Boekstegers P, Hatzopoulos AK (2005) Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia. FASEB J 19:1576-1578. doi: 10.1096/fj.04-3282fje (Pubitemid 41279036)
30. Lassaletta AD, Chu LM, Sellke FW (2011) Therapeutic neovascularization for coronary disease: current state and future prospects. Basic Res Cardiol 106:897-909. doi: 10.1007/s00395-011-0200-1
31. Liehn EA, Postea O, Curaj A, Marx N (2011) Repair after myocardial infarction, between fantasy and reality: the role of chemokines. J Am Coll Cardiol 58:2357-2362. http://dx.doi.org/10.1016/j.jacc.2011.08.034
32. Liehn EA, Schober A, Weber C (2004) Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 24:1891-1896. doi: 10.1161/01.ATV.0000143135.71440.75 (Pubitemid 39350309)
33. Liehn EA, Tuchscheerer N, Kanzler I, Drechsler M, Fraemohs L, Schuh A, Koenen RR, Zander S, Soehnlein O, Hristov M, Grigorescu G, Urs AO, Leabu M, Bucur I, Merx MW, Zernecke A, Ehling J, Gremse F, Lammers T, Kiessling F, Bernhagen J, Schober A, Weber C (2011) Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol 58:2415-2423. http://dx.doi.org/10.1016/j.jacc.2011.08.033
34. Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J (2002) Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4:449-460 pii:S1286457902015605 (Pubitemid 34270682)
35. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 95:9448-9453 (PMCID: PMC21358Immunology) (Pubitemid 28506251)
36. Mammoto A, Connor KM, Mammoto T, Yung CW, Huh D, Aderman CM, Mostoslavsky G, Smith LE, Ingber DE (2009) A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 457:1103-1108. doi: 10.1038/nature07765
37. Poss J, Werner C, Lorenz D, Gensch C, Bohm M, Laufs U (2010) The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice. Basic Res Cardiol 105:725-735. doi: 10.1007/s00395-010-0120-5
38. Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107:1164-1169. doi: 10.1161/01.CIR.0000058702.69484.A0 (Pubitemid 36297209)
39. Schober A, Bernhagen J, Thiele M, Zeiffer U, Knarren S, Roller M, Bucala R, Weber C (2004) Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 109:380-385. doi: 10.1161/01.CIR.0000109201.72441. 09 (Pubitemid 38133908)
40. Schober A, Knarren S, Lietz M, Lin EA, Weber C (2003) Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 108:2491-2497. doi: 10.1161/01.CIR.0000099508.76665.9A (Pubitemid 37444411)
41. Schuh A, Liehn EA, Sasse A, Hristov M, Sobota R, Kelm M, Merx MW, Weber C (2008) Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model. Basic Res Cardiol 103:69-77. doi: 10.1007/s00395-007-0685-9 (Pubitemid 50002796)
42. Simons D, Grieb G, Hristov M, Pallua N, Weber C, Bernhagen J, Steffens G (2011) Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment. J Cell Mol Med 15:668-678. doi: 10.1111/j.1582-4934-2010-01-041.x
43. Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, Laham RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK (2000) Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 102:E73-E86. doi: 10.1161/01.CIR.102.11.e73
44. Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engelhardt B, Vestweber D, Hatzopoulos AK (2003) Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 197:1755-1765. doi: 10.1084/jem.20021659 (Pubitemid 36745350)
45. Walcher D, Vasic D, Heinz P, Bach H, Durst R, Hausauer A, Hombach V, Marx N (2010) LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration. Basic Res Cardiol 105:487-494. doi: 10.1007/s00395-010-0092-5
46. Walenta KL, Bettink S, Bohm M, Friedrich EB (2011) Differential chemokine receptor expression regulates functional specialization of endothelial progenitor cell subpopulations. Basic Res Cardiol 106:299-305. doi: 10.1007/s00395-010-0142-z
47. Zernecke A, Bernhagen J, Weber C (2008) Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117:1594-1602. doi: 10.1161/CIRCULATIONAHA.107.729125 (Pubitemid 351440647)